Skip to main content

Table 2 Utility values of COVID-19 disease based on clinical characteristics

From: The health-related quality of life in Iranian patients with COVID-19

Sociodemographic and clinical characteristics

Number (%)

Utility value

P-value

Mean (SE)

Median (IQR)

Total

287 (100)

0.863 (0.01)

0.909 (0.21)

 

Having underlying disease

 Yes

107 (37.28)

0.818 (0.02)

0.886 (0.26)

<  0.01

 No

180 (62.72)

0.889 (0.01)

0.923 (0.08)

Patient’s condition

 Quarantine at home

123 (42.86)

0.896 (0.02)

0.98 (0.13)

0.01

 General wards hospitalized

147 (51.22)

0.847 (0.01)

0.886 (0.24)

 ICU hospitalized-non-intubated

13 (4.53)

0.766 (0.06)

0.808 (0.21)

 ICU hospitalized-intubated

4 (1.39)

0.629 (0.13)

0.727 (0.33)

Hospitalized days

 1 day

77 (26.83)

0.872 (0.02)

0.915 (0.19)

0.33

 1–4 days

115 (40.07)

0.875 (0.02)

0.931 (0.17)

 Over 4 days

95 (33.10)

0.840 (0.02)

0.896 (0.25)

Blood oxygen saturation

 Normal (over 95%)

70 (24.39)

0.881 (0.01)

0.904 (0.19)

0.33

 Below normal (under 95%)

217 (75.61)

0.857 (0.01)

0.923 (0.21)

Degree of lung involvement

 Non/minor involved

64 (22.30)

0.927 (0.01)

0.966 (0.11)

<  0.01

 Poorly involved

190 (66.20)

0.844 (0.01)

0.894 (0.24)

 Moderately involved

28 (9.76)

0.859 (0.04)

0.969 (0.20)

 Severely involved

5 (1.74)

0.651 (0.11)

0.684 (0.24)

Perceived total health status (VASa)

 > 0.7

206 (71.78)

0.869 (0.01)

0.917 (0.17)

0.19

 0.5–0.7

23 (8.01)

0.894 (0.03)

0.969 (0.23)

 <  0.5

58 (20.21)

0.826 (0.02)

0.864 (0.26)

  1. aVisual Analogue Scale